stars 1 stars 2 stars 3

BioTraceIT Corporation has developed PainTrace®. The only devices for non-invasive and continuous acute and chronic pain monitoring with real-time visualization. The company’s approach uses wearable medical devices to measure pain through the acquisition of direct biosignals that quantify the nervous system’s response to pain. The device provides an instantaneous, real time, numeric readout indicating a level of pain (or the absence of pain). Pain measurements can be stored and transmitted wirelessly, allowing healthcare providers to track and analyze a patient’s pain level during exams or over follow-up periods. Quantify pain levels can potentially aid healthcare providers to target the most effective treatments and also evaluate patients' outcomes to improve pain management and positively impact an individual's return to wellness. Pursuant to FDA regulations, PainTrace® is currently for veterinary use or for research use only in humans.

BioTraceIT Questions

Deborah Dullen is the President of BioTraceIT.

7 people are employed at BioTraceIT.

Top BioTraceIT Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users